The firm is actively filing Stryker ABG II lawsuits for those who have suffered serious complications allegedly caused by the metal-on-metal hip device recalled in 2012.
Find out how much your case is worth.
Online PR News – 30-September-2013 –The U.S. Food and Drug Administration announced recently that it has developed a system of unique identification numbers for medical devices, a move it says will improve the quality of information in medical device adverse events reports, according to an announcement from the agency.* The Rottenstein Law Group LLP, which maintains an informational Stryker hip replacement lawsuit website, sees this as a positive development for patient safety that would have been helpful for patients with metal-on-metal hip implants who have suffered from the devices’ alleged adverse side effects.
The Unique Device Identification System will allow the FDA to identify product problems more quickly and better target recalls, according to the FDA announcement. The system has two distinct features: (1) The device manufacturer assigns a unique number to a device that points toward product-specific information; and (2) A searchable database that functions as a reference catalog for each uniquely identified device. Stryker recalled both its ABG II and Rejuvenate hip implants in June 2012.
“These are the types of systems that should be in place to ensure patient safety and reaffirm the accountability of those who manufacture these devices,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.
Metal poisoning, or “metallosis,” is among the most noted alleged side effects of metal-on-metal hip implants such as the Stryker ABG II and Rejuvenate, according to the U.S. Food and Drug Administration.** Metallosis occurs when metal debris from the friction between the implant’s metal components flakes off into and accumulates in a patient’s bloodstream.
In June 2013, approximately 300 Stryker lawsuits were consolidated in federal court in Minnesota, according to court documents (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation; MDL-2441, U.S. District Court for the District of Minnesota). There are also nearly 400 lawsuits consolidated in New Jersey Superior Court, according to court documents (In re: Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation; MCL-296, Bergen County Superior Court). The cases were consolidated in either jurisdiction to make pretrial proceedings more efficient.
The Rottenstein Law Group LLP represents clients nationally in metal-on-metal hip implant lawsuits. The firm encourages those who believe they have suffered from the alleged adverse side effects to visit the firm’s FAQ page to quickly learn more about side effects and how to go about filing a lawsuit. To stay updated on Stryker hip news, visit the firm’s Stryker Lawsuit Facebook page.
About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com